Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A four-drug combination cured all individuals who had experienced prior treatment failure.
Viral hepatitis is linked to adverse outcomes in pregnant people, underscoring the need for hepatitis B and C screening.
Latino individuals are at higher risk for NAFLD, but Black people with NAFLD are more likely to develop cirrhosis.
Intensive lifestyle management led to weight loss and reduced steatosis and fibrosis.
Pairing HCV testing and treatment eliminates the need to navigate the medical system.
Abdominal obesity worsened the impact of air pollution on MAFLD development.
The drug, which blocks entry of HBV into liver cells, also prevents HDV replication.
Hepatocellular carcinoma can still occur after hepatitis C is cured, and risk factors differ for people with and without cirrhosis.
Over the next two decades, obesity-linked NASH will lead to more deaths and high cost in the United States.
Even with this increase, older individuals now have better transplant outcomes.
HCV treatment initiation dropped by 31% from March to April 2020 and remained low throughout the year.
People with HIV had fewer cirrhosis-related complications but greater healthcare utilization.
Research has shown that elevated levels of iron in the blood from hereditary hemochromatosis can raise the risk of HCC.
The number of people treated for hepatitis C hit a low point during the COVID-19 pandemic.
I always wanted to go to hear firsthand how I could continue to live with end-stage liver failure.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.